Overview: This page contains the latest trade data of Blood, antisera, vaccines, toxins and cultures. In 2018, Blood, antisera, vaccines, toxins and cultures were the world's 12th most traded product, with a total trade of $192B. Between 2017 and 2018 the exports of Blood, antisera, vaccines, toxins and cultures grew by 21.6%, from $158B to $192B. Trade in Blood, antisera, vaccines, toxins and cultures represent 1.04% of total world trade.

Exports: In 2018 the top exporters of Blood, antisera, vaccines, toxins and cultures were Ireland ($32.9B), Germany ($29.7B), Switzerland ($28B), United States ($27.2B), and Belgium-Luxembourg ($16.2B).

Imports: In 2018 the top importers of Blood, antisera, vaccines, toxins and cultures were United States ($39B), Germany ($19.1B), Belgium-Luxembourg ($16.3B), Netherlands ($11.5B), and Switzerland ($9.9B).

Tariffs: In 2018 the average tariff for Blood, antisera, vaccines, toxins and cultures was 1.87%, been the 1247 lowest tariff using the HS4 product classification.

The countries with the highest import tariffs for Blood, antisera, vaccines, toxins and cultures are Iran (20%), Pakistan (8.69%), India (8.18%), Romania (6.86%), and Ethiopia (6.6%). The countries with the lowest tariffs are Angola (0%), Cote d'Ivoire (0%), Egypt (0%), Ghana (0%), and Guinea (0%).

Ranking: Blood, antisera, vaccines, toxins and cultures ranks 110th in the Product Complexity Index (PCI).